As clinical trials become more complex and decentralized, the role of the CRA is evolving from site monitor to strategic, digitally fluent partner, requiring expertise in hybrid oversight, risk-based monitoring, and multi-system data management.
Helen Yeardley
Advertisement
Senior Vice President, Global Clinical Operations, ICON plc
Articles by Helen Yeardley
Adjusting to the changing dynamics of the clinical research associate role.
Advertisement
Latest Updated Articles
The CRA of the Future: From ‘Road Warrior’ to Site ‘Owner’Published: February 13th 2024 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Imfinzi Plus FLOT for Early and Locally Advanced Gastric and GEJ Cancers
2
Is Artificial Intelligence Coming for Clinical Research?
3
FDA Clears Itvisma as First Gene Therapy for Adolescents and Adults With SMA
4
The CRA Role’s Co-evolution With Clinical Trial Technology
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
